Diltiazem 12HR ER 60 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB26FW4L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,295
Award facts
- Contract value 100% obligated
- $1,295.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Diltiazem 12-hour extended-release 60 mg capsules (100 count) with a ceiling value of $1,295.39. This firm fixed-price delivery order, with an ultimate completion date of November 5, 2025, was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs.
As a child contract under the SPE2DX vehicle, this delivery order exemplifies the routine pharmaceutical procurement conducted through DLA's established medical supply chain. Diltiazem is a calcium channel blocker commonly used in military and veteran healthcare systems for cardiovascular disease management. AmerisourceBergen's position as a prime vendor under the SPE2DX framework enables efficient fulfillment of federal medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio and demonstrated capability to meet open competition standards position it as a critical vendor for sustaining pharmaceutical inventories across the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FW4L5?
SPE2DB26FW4L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FW4L5 worth?
The government has obligated $1,295 on SPE2DB26FW4L5.
Is contract SPE2DB26FW4L5 an order under another contract?
Yes. SPE2DB26FW4L5 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB26FW4L5 competed?
The extent of competition for SPE2DB26FW4L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award